https://drugnews.com.tw/articles/2026-08-29-revolution-rasonque-pancreatic-cancer-ras-on-en.html Drugnews｜藥時事 en 2026-08-29T00:00:00.000Z Pancreatic Cancer Finally Gets a Broad RAS(ON) Drug: Inside RASONQUE's FDA Approval https://drugnews.com.tw/articles/2026-08-29-revolution-rasonque-pancreatic-cancer-ras-on.html Drugnews｜藥時事 zh-tw 2026-08-29T00:00:00.000Z 胰臟癌終於被撬開一道縫！FDA 提前 6.5 個月批准首款廣譜 RAS 新藥 https://drugnews.com.tw/articles/2026-08-28-zealand-rusfertide-royalty-pharma-pv-en.html Drugnews｜藥時事 en 2026-08-28T00:00:00.000Z A New Rival for PharmaEssentia? What Zealand Actually Sold for $100 Million https://drugnews.com.tw/articles/2026-08-28-zealand-rusfertide-royalty-pharma-pv.html Drugnews｜藥時事 zh-tw 2026-08-28T00:00:00.000Z 藥華藥迎新對手？1 億美元賣分潤